ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Kenneth Olden Named Director Of Howard Cancer Center; Calhoon Sparked AMA On Cigarette Ads

February 21, 1986

In Brief: New Contract To Speed Drug Development Planned; Groups To Get $5.6 Million Extra

February 27, 1976

ACCC Established FCCC Special Interest Group

April 11, 1986

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014

HHS News: Shalala To Form Genetic Testing Advisory Committee

August 14, 1998

Cooperative Group Problems, Solutions Analyzed By CTEP Staff

May 2, 1986